Literature DB >> 415878

Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis.

E Feliu, M A Gougerot, J Hakim, E Cramer, C Auclair, B Rueff, P Boivin.   

Abstract

Polymorphonuclear leucocyte function was investigated in twenty patients with alcoholic cirrhosis and three patients with cryptogenic cirrhosis. Bacterial ingestion, oxygen-dependent bactericidal capacity, and chemotactic response were measured. Serum dependent abnormalities were common; they included deficiencies of ingestion and of all subsequent oxygen-dependent metabolic events (three patients), all oxygen-dependent metabolic events (one patient), cytochrome c reduction and iodination deficiencies (six patients), isolated cytochrome c reduction deficiency (ten patients), and chemotactic deficiencies (fourteen out of eighteen patients). Serum-independent abnormalities were much less common; they included increased ingestion rate (four patients), decreased stimulated reduction of nitroblue tetrazolium (three patients), and decreased myeloperoxidase content (eight patients). Polymorphonuclear leucocyte abnormalities are frequent in cirrhosis and may account in part for increased susceptibility to infection in that disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 415878     DOI: 10.1111/j.1365-2362.1977.tb01653.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease.

Authors:  I A Rajkovic; A G Yousif-Kadaru; R J Wyke; R Williams
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

3.  Defects in serum attractant activity in different types of chronic liver disease.

Authors:  A G Yousif-Kadaru; I A Rajkovic; R J Wyke; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

4.  Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.

Authors:  F Trevisani; E Castelli; F G Foschi; M Parazza; E Loggi; M Bertelli; C Melotti; M Domenicali; G Zoli; M Bernardi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.

Authors:  Carmen Fiuza; Magdalena Salcedo; Gerardo Clemente; Jose M Tellado
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Neutrophil adherence in chronic liver disease and fulminant hepatic failure.

Authors:  M Altin; I A Rajkovic; R D Hughes; R Williams
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

7.  Decreased production of active oxygen species by neutrophils in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  K Itoh; A Nakao; W Kishimoto; T Itoh; A Harada; T Nonami; M Nakano; H Takagi
Journal:  Gastroenterol Jpn       Date:  1993-08

8.  Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.

Authors:  M A De Fernandez; A Clark; D R Triger
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 9.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Differential in vivo effects of indomethacin, ibuprofen, and flurbiprofen on oxygen-dependent killing activities of neutrophils elicited by acute nonimmune inflammation in the rat.

Authors:  A Perianin; J P Giroud; J Hakim
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.